Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Silverman

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Current Osteoporosis Reports|October 1, 2013
Measuring osteoporosis quality: The work of the Joint CommissionStuart Silverman
Menopause (New York, N.Y.)|February 13, 2014
Individualizing osteoporosis medicationsStuart Silverman
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 15, 2009
Selecting patients for osteoporosis therapyStuart Silverman
Rheumatic Diseases Clinics of North America|February 10, 2007
Adherence to medications for the treatment of osteoporosisStuart Silverman
The American Journal of Medicine|March 28, 2006
Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problemJoyce A Cramer, Stuart Silverman
Reviews in Endocrine & Metabolic Disorders|May 6, 2010
Compliance and persistence with osteoporosis medications: a critical review of the literatureStuart Silverman, Deborah T Gold
Current Osteoporosis Reports|March 11, 2006
Review of adherence to medications for the treatment of osteoporosisDeborah T Gold, Stuart Silverman
The American Journal of Managed Care|July 1, 2010
Optimizing the management of fibromyalgia. IntroductionStuart Silverman, William J Cardarelli
Current Osteoporosis Reports|October 31, 2018
Medication Decision-making in Osteoporosis: Can We Explain Why Patients Do Not Take Their Osteoporosis Medications?Stuart Silverman, Deborah T Gold
The American Journal of Managed Care|July 1, 2010
Pregabalin: an alpha2-delta (alpha2-delta) ligand for the management of fibromyalgiaLesley Arnold, Philip Mease, Stuart Silverman
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Current Osteoporosis Reports|October 1, 2013
Measuring osteoporosis quality: The work of the Joint CommissionStuart Silverman
Menopause (New York, N.Y.)|February 13, 2014
Individualizing osteoporosis medicationsStuart Silverman
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 15, 2009
Selecting patients for osteoporosis therapyStuart Silverman
Rheumatic Diseases Clinics of North America|February 10, 2007
Adherence to medications for the treatment of osteoporosisStuart Silverman
The American Journal of Medicine|March 28, 2006
Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problemJoyce A Cramer, Stuart Silverman
Reviews in Endocrine & Metabolic Disorders|May 6, 2010
Compliance and persistence with osteoporosis medications: a critical review of the literatureStuart Silverman, Deborah T Gold
Current Osteoporosis Reports|March 11, 2006
Review of adherence to medications for the treatment of osteoporosisDeborah T Gold, Stuart Silverman
The American Journal of Managed Care|July 1, 2010
Optimizing the management of fibromyalgia. IntroductionStuart Silverman, William J Cardarelli
Current Osteoporosis Reports|October 31, 2018
Medication Decision-making in Osteoporosis: Can We Explain Why Patients Do Not Take Their Osteoporosis Medications?Stuart Silverman, Deborah T Gold
The American Journal of Managed Care|July 1, 2010
Pregabalin: an alpha2-delta (alpha2-delta) ligand for the management of fibromyalgiaLesley Arnold, Philip Mease, Stuart Silverman
Pageof 10